PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90705527 |
Filing Date: 05/12/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90705527 |
---|---|
MARK INFORMATION | |
*MARK | NUVU |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | NUVU |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Orasis Pharmaceuticals Ltd. |
*MAILING ADDRESS | 6 Maskit st., P.O.B 12929 |
*CITY | Herzliya |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Israel |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
4673328 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | limited liability company |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Israel |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for treatment of eye disorders and diseases |
FILING BASIS | SECTION 1(b) |
FILING BASIS | SECTION 44(d) |
FOREIGN APPLICATION NUMBER | 338842 |
FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Israel |
FOREIGN FILING DATE | 04/29/2021 |
INTENT TO PERFECT 44(d) |
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained. |
ATTORNEY INFORMATION | |
NAME | B. Brett Heavner |
ATTORNEY DOCKET NUMBER | 13954.0011 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Finnegan, Henderson, Farabow, Garrett & Dunner, LLP |
STREET | 901 New York Avenue NW |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20001 |
PHONE | 202-408-4000 |
FAX | 202-408-4400 |
EMAIL ADDRESS | docketing@finnegan.com |
OTHER APPOINTED ATTORNEY | all other attorneys of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP |
CORRESPONDENCE INFORMATION | |
NAME | B. Brett Heavner |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | docketing@finnegan.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | takisha.diaz@finnegan.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /ELAD KEDAR/ |
SIGNATORY'S NAME | Elad Kedar |
SIGNATORY'S POSITION | CEO |
SIGNATORY'S PHONE NUMBER | 202-408-4000 |
DATE SIGNED | 05/12/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 04/30/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90705527 |
Filing Date: 05/12/2021 |
The applicant's current Correspondence Information: |
B. Brett Heavner |
PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): takisha.diaz@finnegan.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|